FUNDING ALERT
Empire State Stem Cell Board issues RFPs for $105 million in stem cell funding
INVESTIGATOR INITIATED RESEARCH PROJECTS AND INNOVATIVE, DEVELOPMENTAL OR EXPLORATORY ACTIVITIES (IDEA) IN STEM CELL RESEARCH
The ESSCB wishes to stimulate and support basic, applied (mechanistic, technological), translational, pre-clinical and clinical scientific investigations on any aspect of stem cell biology that will lead to a better understanding of the unique properties of stem cells and allow their utilization to treat disease. Research in the area of human embryonic stem cells is encouraged, as are studies that promote translation of stem cell science to therapeutic applications, such as new approaches to directed differentiation, including lineage differentiation (or transdifferentiation).
The number of awards and total funds awarded per application will be contingent upon the quality of applications submitted as well as the size and scope of the proposed projects. Approximately $25 million is available to support approximately 34 awards from this RFA. Based on its assessment that the field is ready to pursue additional investigations, the Funding Committee of the ESSCB may determine that additional funds should be made available under this RFA to support additional awards.
Applications due DECEMBER 1, 2011.
------------------------------------------------------------------------
CONSORTIA TO ACCELERATE THERAPEUTIC APPLICATIONS OF STEM CELLS
The New York State Department of Health invites eligible applicants to submit applications in response to this Request for Applications (RFA), which provides funding to accelerate translational and preclinical through clinical applications of stem cell research for prevention and/or treatment of disease.
Through this RFA, the ESSCB wishes to accelerate translational and preclinical through clinical applications of stem cell research for prevention and/or treatment of disease. The intent of these milestone-based awards is to support disease-focused, health outcome-based, multi-disciplinary collaborative research proposals. Such proposals will address an unmet medical need using stem cells as a basis for the development of clinical treatments/therapies or will apply a new technology or platform based on stem cells. This RFA seeks to fund applications presenting a coherent, goal-oriented project and is not intended to address a series of separate but inter- related projects as would an NIH Program Project or Center grant.
A maximum of $80 million is available to support approximately five awards from this RFA.
Applications due OCTOBER 17, 2011.
------------------------------------------------------------------------
SCIENTIFIC OVERSIGHT OF STEM CELL CONSORTIA
This RFP seeks bids from any fiscally and legally responsible entity with demonstrated expertise in independent continuous scientific peer review and oversight. The bidder must be a recognized legal entity (e.g., LLC or Inc.) rather than unincorporated individuals. Bidders should have experience in all aspects of independent continuous scientific peer review and oversight including, but not limited to, panel member recruitment and composition, meeting planning and facilitation, coordination of travel, lodging and other logistics, evaluation of scientific progress of multi-disciplinary projects, group facilitation, and scientific report writing.
Application deadline SEPTEMBER 15, 2011.
